Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,902.77 +799.04 (+1.21%) CMC Crypto 200
1,368.59 -5.25 (-0.38%)
Glenmark Pharmaceuticals Limited (GLENMARK.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 12:29PM IST
Currency in INR
Valuation measures4
| Market cap (intra-day) | 287.70B |
| Enterprise value | 326.02B |
| Trailing P/E | N/A |
| Forward P/E | 14.90 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.24 |
| Price/book (mrq) | 3.08 |
| Enterprise value/revenue | 2.53 |
| Enterprise value/EBITDA | 61.44 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.88 |
| 52-week change 3 | 68.46% |
| S&P500 52-week change 3 | 26.49% |
| 52-week high 3 | 1,098.00 |
| 52-week low 3 | 581.20 |
| 50-day moving average 3 | 998.71 |
| 200-day moving average 3 | 862.05 |
Share statistics
| Avg vol (3-month) 3 | 30.18k |
| Avg vol (10-day) 3 | 14.77k |
| Shares outstanding 5 | 282.19M |
| Implied shares outstanding 6 | 284.47M |
| Float 8 | 138.17M |
| % held by insiders 1 | 50.97% |
| % held by institutions 1 | 25.78% |
| Shares short 4 | N/A |
| Short ratio 4 | N/A |
| Short % of float 4 | N/A |
| Short % of shares outstanding 4 | N/A |
| Shares short (prior month ) 4 | N/A |
Dividends & splits
| Forward annual dividend rate 4 | 2.5 |
| Forward annual dividend yield 4 | 0.25% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 0.50 |
| Payout ratio 4 | 27.72% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | 18 Sept 2023 |
| Last split factor 2 | 2:1 |
| Last split date 3 | 10 Sept 2007 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Mar 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -5.41% |
| Operating margin (ttm) | -14.19% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 131.58B |
| Revenue per share (ttm) | 466.24 |
| Quarterly revenue growth (yoy) | -27.60% |
| Gross profit (ttm) | N/A |
| EBITDA | 15.79B |
| Net income avi to common (ttm) | -7.64B |
| Diluted EPS (ttm) | -27.12 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 11.24B |
| Total cash per share (mrq) | 39.83 |
| Total debt (mrq) | 51.82B |
| Total debt/equity (mrq) | 53.22% |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 330.08 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2024 Yahoo. All rights reserved.